🇺🇸 FDA
Patent

US 6936731

Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same

expired A61KA61K31/225

Quick answer

US patent 6936731 (Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same) held by TEVA Gyógyszergyár Részvénytársaság expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA Gyógyszergyár Részvénytársaság
Grant date
Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/225